Viewing Study NCT00001872



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00001872
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 1999-11-03

Brief Title: Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Sponsor: National Heart Lung and Blood Institute NHLBI
Organization: National Institutes of Health Clinical Center CC

Study Overview

Official Title: Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease
Status: COMPLETED
Status Verified Date: 2018-03-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Blood contains different kinds of cells white blood cells red blood cells and platelets In order to treat certain diseases specific cell types can be removed from blood and transplanted into patients The process of removing white blood cells for the treatment of leukemia is called apheresis

This study will make available blood cell collections from volunteers genetically matched to various degrees with recipients in order to test and if necessary refine the process of removing white blood cell T-lymphocytes
Detailed Description: This protocol has been written to make available apheresis collections from volunteers matched to various degrees with recipients in order to test and if necessary refine the selective immunodepletion procedure prior to introducing it in a clinical trial

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
99-H-0037 None None None